Medina-Martinez Ingrid, Barrón Valeria, Roman-Bassaure Edgar, Juárez-Torres Eligia, Guardado-Estrada Mariano, Espinosa Ana María, Bermudez Miriam, Fernández Fernando, Venegas-Vega Carlos, Orozco Lorena, Zenteno Edgar, Kofman Susana, Berumen Jaime
Unidad de Medicina Genómica, Facultad de Medicina, Universidad Nacional Autónoma de México/Hospital General de México, México, D.F. México.
Servicio de Oncología, Hospital General de México, México, D.F. México.
PLoS One. 2014 May 30;9(5):e97842. doi: 10.1371/journal.pone.0097842. eCollection 2014.
We investigated the role of tumor copy number (CN)-altered genome (CN-AG) in the carcinogenesis of cervical cancer (CC), especially its effect on gene expression, biological processes, and patient survival. Fifty-nine human papillomavirus 16 (HPV16)-positive CCs were investigated with microarrays-31 for mapping CN-AG and 55 for global gene expression, with 27 CCs in common. Five-year survival was investigated in 55 patients. Deletions and amplifications >2.5 Mb were defined as CN alterations. The %CN-AG varied from 0 to 32.2% (mean = 8.1±8.9). Tumors were classified as low (mean = 0.5±0.6, n = 11), medium (mean = 5.4±2.4, n = 10), or high (mean = 19.2±6.6, n = 10) CN. The highest %CN-AG was found in 3q, which contributed an average of 55% of all CN alterations. Genome-wide, only 5.3% of CN-altered genes were deregulated directly by gene dosage. In contrast, the rate in fully duplicated 3q was twice as high. Amplification of 3q explained 23.2% of deregulated genes in whole tumors (r2 = 0.232, p = 0.006; analysis of variance), including genes located in 3q and other chromosomes. A total of 862 genes were deregulated exclusively in high-CN tumors, but only 22.9% were CN altered. This suggests that the remaining genes are not deregulated directly by gene dosage, but by mechanisms induced in trans by CN-altered genes. Anaphase-promoting complex/cyclosome (APC/C)-dependent proteasome proteolysis, glycolysis, and apoptosis were upregulated, whereas cell adhesion and angiogenesis were downregulated exclusively in high-CN tumors. The high %CN-AG and upregulated gene expression profile of APC/C-dependent proteasome proteolysis were associated with poor patient survival (p<0.05, log-rank test). Along with glycolysis, they were linearly associated with FIGO stage (r>0.38, p<0.01, Spearman test). Therefore, inhibition of APC/C-dependent proteasome proteolysis and glycolysis could be useful for CC treatment. However, whether they are indispensable for tumor growth remains to be demonstrated.
我们研究了肿瘤拷贝数(CN)改变的基因组(CN-AG)在宫颈癌(CC)致癌过程中的作用,特别是其对基因表达、生物学过程和患者生存的影响。我们用微阵列研究了59例人乳头瘤病毒16型(HPV16)阳性的CC,其中31例用于绘制CN-AG图谱,55例用于全基因组基因表达研究,共有27例CC样本重复检测。我们对55例患者进行了5年生存率调查。缺失和扩增>2.5 Mb被定义为CN改变。CN-AG的比例从0到32.2%不等(平均=8.1±8.9)。肿瘤被分为低CN(平均=0.5±0.6,n=11)、中CN(平均=5.4±2.4,n=10)或高CN(平均=19.2±6.6,n=10)。在3q中发现了最高的CN-AG比例,其平均占所有CN改变的55%。在全基因组范围内,只有5.3%的CN改变基因因基因剂量直接失调。相比之下,在完全复制的3q中这一比例是其两倍。3q的扩增解释了整个肿瘤中23.2%的失调基因(r2=0.232,p=0.006;方差分析),包括位于3q和其他染色体上的基因。共有862个基因仅在高CN肿瘤中失调,但只有22.9%的基因有CN改变。这表明其余基因并非因基因剂量直接失调,而是由CN改变基因在反式作用中诱导的机制所导致。后期促进复合物/细胞周期体(APC/C)依赖性蛋白酶体蛋白水解、糖酵解和凋亡在高CN肿瘤中上调,而细胞黏附和血管生成仅在高CN肿瘤中下调。高CN-AG以及APC/C依赖性蛋白酶体蛋白水解的上调基因表达谱与患者不良生存相关(p<0.05,对数秩检验)。与糖酵解一起,它们与国际妇产科联盟(FIGO)分期呈线性相关(r>0.38,p<0.01,Spearman检验)。因此,抑制APC/C依赖性蛋白酶体蛋白水解和糖酵解可能对CC治疗有用。然而,它们对肿瘤生长是否不可或缺仍有待证实。